It was hard to miss CoCo Vandeweghe’s commercial for the Masimo MightySat during Indian Wells. The 30-second ad for the newly released fingertip pulse oximeter played on nearly every changeover.

The company gained FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter (OTC) to consumers without a prescription in February. MASI has three ...

Masimo (NASDAQ: MASI ... and Radius VSM™, portable devices like Rad-67®, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such ...

Masimo is up 10.4% since the beginning of the year, and at $186.09 per share, has set a new 52-week high. Investors who bought $1,000 worth of Masimo’s shares 5 years ago would now be looking at ...

BTIG analyst Marie Thibault raised the firm’s price target on Masimo (MASI) to $206 from $178 and keeps a Buy rating on the shares after its Q4 earnings beat. The company is moving quickly with ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...